Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Cash Flow from Investing Activities

    Back to Cashflow Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Cash Flow from Investing Activities ₹-18 Cr₹83 Cr₹-45 Cr₹-27 Cr₹-18 Cr

What is the latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) is ₹-18 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹-18 Cr
Mar2024₹83 Cr
Mar2023₹-45 Cr
Mar2022₹-27 Cr
Mar2017₹-18 Cr

How is Cash Flow from Investing Activities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹-18 Cr
Negative
Mar2024 ₹83 Cr
Positive
Mar2023 ₹-45 Cr
Negative
Mar2022 ₹-27 Cr
Negative
Mar2017 ₹-18 Cr -

Compare Cash Flow from Investing Activities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,454.2 Cr -1.6% -6.2% -23% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,412.0 Cr -0.4% 6.4% 4.2% Stock Analytics
DIVIS LABORATORIES ₹170,343.0 Cr -1.5% -4.9% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,191.0 Cr -0.7% 4.8% 16.6% Stock Analytics
CIPLA ₹122,511.0 Cr -0.5% 1% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,523.0 Cr 2.2% 6.6% 5.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-1.6%

-6.2%

-23%

SENSEX

0.7%

0.9%

6.1%


You may also like the below Video Courses